Remdesivir in adults with severe COVID-19 : a randomised, double-blind, placebo-controlled, multicentre trial - Wang, Yeming; Zhang, Dingyu; Du, Guanhua; Du, Ronghui; Zhao, Jianping; Jin, Yang; Fu, Shouzhi; Gao, Ling; Cheng, Zhenshun; Lu, Qiaofa; Wang, Ke; Lu, Yang; et al.
In: The Lancet, 2020 Vol. 395 (10236) page 1569-1578
Keywords: Nucleosides; Prodrugs; Coronavirus; Remdesivir; COVID-19